Table of contents

ORIGINAL ARTICLE

• Survival and prognostic factors in early-stage epithelial ovarian carcinoma treated with taxane-based adjuvant chemotherapy (1 October, 2007)

  I. Skírnisdóttir, B. Sorbe
• Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer (1 October, 2007)

  P. Harter, K. Gnauert, R. Hils, T. G. Lehmann, A. Fisseler-Eckhoff, A. Traut, A. Du Bois
• Bulky lymph node resection in patients with recurrent epithelial ovarian cancer: impact of surgery (1 October, 2007)

  P Benedetti Panici, G. Perniola, R. Angioli, M. A. Zullo, N. Manci, I. Palaia, F. Bellati, F. Plotti, M. Calcagno, S. Basile
• Prognostic factors associated with brain metastases from epithelial ovarian carcinoma (1 October, 2007)

  T.-J. Kim, S. Song, C. K. Kim, W. Y. Kim, C. H. Choi, J.-H. Lee, J.-W. Lee, D.-S. Bae, B.-G. Kim
• Design of a bio-mathematical prediction model using serum tumor markers and immunohistochemistry in peritoneal carcinomatosis with ovarian involvement: a pilot study (1 October, 2007)

  Z. Khatami, P. Cross, M. R. Stevenson, R. Naik
• Radical hysterectomy for cervical cancer amongst women infected with the human immunodeficiency virus (1 October, 2007)

  M. Moodley
• The relationship between human papillomavirus infection and cervical intraepithelial neoplasia in Turkish women (1 October, 2007)

  M. M. Inal, Ş. KÖSE, Y. Yildirim, Y. ÖZDEMIR, E. TÖZ, K. Ertopçu, İ. ÖZELMAS, Ş. Tinar
• Persistence of human papillomavirus as a predictor for treatment failure after loop electrosurgical excision procedure (1 October, 2007)

  J. H. Bae, C. J. Kim, T. C. Park, S. E. Namkoong, J. S. Park
• Differential expression of T-cell CD3-zeta chains in patients with cervical dysplasia before and after treatment (1 October, 2007)

  S. M. Shondel, C. W. Helm, C. Gercel-Taylor, D. D. Taylor
• Overexpressed active Notch1 induces cell growth arrest of HeLa cervical carcinoma cells (1 October, 2007)

  L. Wang, H. Qin, B. Chen, X. Xin, J. Li, H. Han
• Expression of differentiation associated protein Hes1 and Hes5 in cervical squamous carcinoma and its precursors (1 October, 2007)

  J. Liu, F. Ye, H. Chen, W. LÜ, C. Zhou, X. Xie
• Aldo-keto reductase family 1, member B10 in uterine carcinomas: a potential risk factor of recurrence after surgical therapy in cervical cancer (1 October, 2007)

  H. Yoshitake, M. Takahashi, H. Ishikawa, M. Nojima, H. Iwanari, A. Watanabe, H. Aburatani, K. Yoshida, K. Ishi, K. Takamori, H. Ogawa, T. Hamakubo, T. Kodama, Y. Araki
• Human papillomavirus genotype as a prognostic factor in carcinoma of the uterine cervix (1 October, 2007)

  S. Y. Tong, Y. S. Lee, J. S. Park, S. E. Namkoong
• Association of human leukocyte antigen and T cell message with human papillomavirus 16–positive cervical neoplasia in Japanese women (1 October, 2007)

  M. Saito, M. Okubo, R. Hirata, S. Takeda, H. Maeda
• Transvaginal ultrasound and lactate dehydrogenase isoenzyme activity profile in uterine aspirate for diagnosis of endometrial carcinoma in women with postmenopausal bleeding (1 October, 2007)

  O. Niklasson, G. Skude, G. Lingman, B. Casslén, K. Maršál
• Expression of vascular endothelial growth factor and assessment of microvascular density with CD 34 and endoglin in proliferative endometrium, endometrial hyperplasia, and endometrial carcinoma (1 October, 2007)

  O. Erdem, M. Erdem, A. Erdem, L. Memis, G. Akyol